September 2016 Vol 9, No 6
John Barron, PharmD, Yiqiong Xie, PhD, Sze-jung Wu, PhD, Jeff White, PharmD, Joseph R. Singer, MD, Bernard Tulsi, MSc, Alan Rosenberg, MD
Evaluating the True Value of High-Cost Therapies for Hepatitis C Infection
Daniel B. Ng, PharmD, MBA, Melissa McCart, PharmD, MS, Christopher Klein, BS, Chelsey Campbell, PharmD, MBA, Robert Schoenhaus, PharmD, Todd Berner, MD
Implications of Big Data Analysis in the Real-World Setting: The Case of Overactive Bladder Treatment
Results 1 - 5 of 5